• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER HEALTHCARE LLC ALEVE DIRECT THERAPY TENS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR (TENS)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER HEALTHCARE LLC ALEVE DIRECT THERAPY TENS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR (TENS) Back to Search Results
Lot Number 608548
Device Problem Insufficient Information (3190)
Patient Problems Burn(s) (1757); Erythema (1840); Pain (1994); Electric Shock (2554)
Event Date 10/28/2016
Event Type  Injury  
Manufacturer Narrative
This spontaneous case was reported by a consumer and describes the occurrence of medical device site burn ("i have a burn mark where this device was"), medical device site pain ("his hurt really bad. ") and medical device site erythema ("i have a red mark where the device was") in a (b)(6) year-old male patient who received aleve tens device direct therapy unit (batch no. 608548) for pain. Other product or product use issues identified: device stimulation issue "this literally shocked me / felt like he was touching a live 110 watt power line when the device was shocking him" (seriousness criterion medically significant) on (b)(6) 2016. Medical conditions: consumer stated he does not have metal in him and had no phone or metal on him while using the device. Concomitant products included ibuprofen. On an unknown date, the patient started aleve tens device direct therapy unit. On (b)(6) 2016, the patient experienced medical device site burn, medical device site pain and medical device site erythema. Aleve tens device direct therapy unit was withdrawn. At the time of the report, the medical device site burn, medical device site pain and medical device site erythema had not resolved. The reporter provided no causality assessment for medical device site burn with aleve tens device direct therapy unit. The reporter considered medical device site erythema and medical device site pain to be related to aleve tens device direct therapy unit. Diagnostic results (normal ranges are provided in parenthesis if available): body mass index was 24. 2 kg/sqm. Quality-safety evaluation of ptc: device batch documentation has been reviewed by bayer quality assurance. All deviations and non-conformance's have also been reviewed by bayer quality assurance to identify potential product quality concerns, with none identified for the applicable lot. Without a returned device, no further investigation is possible. This issue will be monitored and trended to potentially identify new failure modes. An in depth ptc investigation cannot be conducted by the quality unit as a sample was not provided. The quality unit evaluation was unable to confirm the complaint. Most recent follow-up information incorporated above includes: on 11-oct-2017: quality-safety evaluation result of ptc. This spontaneous case was reported by a consumer and describes the occurrence of electric shock ("this literally shocked me / felt like he was touching a live 110 watt power line when the device was shocking him") in a (b)(6) year-old male patient who received aleve tens device direct therapy unit for pain. This event was considered serious as medically important and unlisted according to aleve tens reference safety information. Consumer stated he does not have metal in him and had no phone or metal on him while using the device. Considering the mechanism of action of device and implied temporal relationship, company does not exclude causality between event and suspect device.
 
Event Description
This spontaneous case was reported by a consumer and describes the occurrence of electric shock ("this literally shocked me / felt like he was touching a live 110 watt power line when the device was shocking him") in a (b)(6) male patient who received aleve tens device direct therapy unit (batch no. T02r6x) for pain. The occurrence of additional non-serious events is detailed below. Medical conditions: consumer stated he does not have metal in him and had no phone or metal on him while using the device. Concomitant products included ibuprofen. On an unknown date, the patient started aleve tens device direct therapy unit unk unk, tid. On (b)(6) 2016, the patient experienced electric shock (seriousness criterion medically significant), medical device site injury ("i have a burn mark where this device was"), medical device site pain ("his hurt really bad. ") and medical device site erythema ("i have a red mark where the device was"). Aleve tens device direct therapy unit was withdrawn. At the time of the report, the electric shock outcome was unknown and the medical device site injury, medical device site pain and medical device site erythema had not resolved. The reporter considered electric shock, medical device site pain and medical device site erythema to be related to aleve tens device direct therapy unit. The reporter provided no causality assessment for medical device site injury with aleve tens device direct therapy unit. Quality-safety evaluation of ptc: batch documentation has been reviewed by bayer quality assurance for all released lots. All deviations and non-conformances have also been reviewed by bayerquality assurance to identify potential product quality concerns. Without a returned sample, no further investigation is possible. This issue will be monitored and trended to potentially identify new failure modes. A ptc investigation cannot be initiated as a batch number or sample was not provided thus resulting in an unconfirmed quality defect. Most recent follow-up information incorporated above includes: on 22-feb-2017: correction: the event this literally shocked me / felt like he was touching a live 110 watt power line when the device was shocking him was recoded and case was upgraded. Incident category was updated. Company causality comment: this spontaneous case was reported by a consumer and describes the occurrence of electric shock ("this literally shocked me / felt like he was touching a live 110 watt power line when the device was shocking him") in a (b)(6) male patient who received aleve tens device direct therapy unit for pain. This event was considered serious as medically important and unlisted according to aleve tens reference safety information. Consumer stated he does not have metal in him and had no phone or metal on him while using the device. Considering the mechanism of action of device and implied temporal relationship, company does not exclude causality between event and suspect device. Further information will be requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameALEVE DIRECT THERAPY TENS
Type of DeviceTRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR (TENS)
Manufacturer (Section D)
BAYER HEALTHCARE LLC
3030 jackson avenue
memphis TN 38151
Manufacturer (Section G)
BAYER HEALTHCARE LLC
3030 jackson avenue
memphis TN 38151
Manufacturer Contact
k. shaw lamberson
100 bayer blvd, p o box 915
whippany, NJ 07981-0915
MDR Report Key6373420
MDR Text Key264987983
Report Number1020060-2017-00002
Device Sequence Number1
Product Code NUH
Combination Product (y/n)N
PMA/PMN Number
K152852
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Reporter Occupation
Type of Report Initial,Followup
Report Date 10/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Lot Number608548
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Event Location No Information
Date Manufacturer Received10/11/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse

Patient Treatment Data
Date Received: 03/02/2017 Patient Sequence Number: 1
Treatment
IBUPROFEN (IBUPROFEN [IBUPROFEN])
-
-